Highlights and Quick Summary
- Change in Cash for the quarter ending June 30, 2023 was $-7.54 Million (a 79.99% increase compared to previous quarter)
- Year-over-year quarterly Change in Cash decreased by -331.24%
- Annual Change in Cash for 2022 was $-6.36 Million (a -122.29% decrease from previous year)
- Annual Change in Cash for 2021 was $28.5 Million (a -309.61% decrease from previous year)
- Annual Change in Cash for 2020 was $-13.6 Million (a -515.0% decrease from previous year)
- Twelve month Change in Cash ending June 30, 2023 was $-15.4 Million (a 51.57% increase compared to previous quarter)
- Twelve month trailing Change in Cash increased by 206.4% year-over-year
Trailing Change in Cash for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $-15.4 Million | $-10.1 Million | $-6.36 Million | $-5.02 Million |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Change in Cash of DURECT Corporation
Most recent Change in Cashof DRRX including historical data for past 10 years.Interactive Chart of Change in Cash of DURECT Corporation
DURECT Corporation Change in Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-7.54 | $-4.19 | – | – | – |
| 2022 | $-6.91 | $3.26 | $-2.31 | $-0.4 | $-6.36 |
| 2021 | $-5.57 | $-0.66 | $-1.47 | $36.23 | $28.53 |
| 2020 | $2.64 | $0.22 | $-14.13 | $-2.35 | $-13.61 |
| 2019 | $-4.8 | $2.78 | $9.3 | $-4.0 | $3.28 |
| 2018 | $-6.57 | $0.88 | $-1.99 | $9.95 | $2.27 |
| 2017 | $-5.91 | $4.88 | $26.13 | $-1.13 | $23.97 |
| 2016 | $0.04 | $-2.67 | $4.18 | $0.27 | $1.82 |
| 2015 | $-1.81 | $-0.6 | $4.0 | $-0.69 | $0.9 |
| 2014 | $-0.74 | $-15.25 | $16.7 | $-5.87 | $-5.16 |
| 2013 | $-1.72 | $1.57 | $-0.26 | $-2.95 | $-3.36 |
| 2012 | $4.91 | $2.13 | – | – | $2.3 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic